GO:0120042 negative regulation of macrophage proliferation: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0120042 describes any process that stops, prevents, or reduces the frequency, rate or extent of macrophage proliferation.
• Macrophage proliferation is tightly controlled by transcription factors such as ATF3, which coordinates survival and proliferation of cardiac macrophages.
• Tumor-associated macrophages often exhibit dysregulated proliferation, and pathways like SPP1-SOCS1 constrain interferon responses to shape an immunosuppressive microenvironment.
• Negative regulation of macrophage proliferation is critical for resolving inflammation and preventing fibrosis, as shown in liver inflammation models.
• Key experimental approaches include conditional knockout, point mutation, and overexpression models to dissect gene function in macrophage proliferation.
• Dysregulation of this process contributes to cancer, cardiovascular disease, and chronic inflammatory conditions.
Description
Macrophages are innate immune cells that play central roles in tissue homeostasis, inflammation, and cancer. Their proliferation must be tightly regulated to avoid excessive accumulation that can drive pathology. GO:0120042, negative regulation of macrophage proliferation, encompasses any process that stops, prevents, or reduces the frequency, rate or extent of macrophage proliferation. This regulation is essential for resolving inflammation and maintaining tissue integrity. For researchers, understanding the molecular players that restrain macrophage proliferation offers therapeutic opportunities in cancer, cardiovascular disease, and fibrosis.
negative regulation of macrophage proliferation At A Glance
| GO ID | GO:0120042 |
|---|---|
| GO term | negative regulation of macrophage proliferation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Restrains macrophage population expansion |
| Related processes | Macrophage proliferation, inflammatory resolution, tissue repair |
| Key regulators | ATF3, SPP1-SOCS1, SIRT1, FAP |
| Disease relevance | Cancer, cardiovascular disease, liver fibrosis, pneumonia |
What Is GO:0120042?
According to the Gene Ontology, GO:0120042 (negative regulation of macrophage proliferation) is defined as any process that stops, prevents, or reduces the frequency, rate or extent of macrophage proliferation. This biological process includes signaling events, transcriptional programs, and cell-intrinsic checkpoints that limit the expansion of macrophage populations.
Why Is negative regulation of macrophage proliferation Important in Cell Biology?
Negative regulation of macrophage proliferation is crucial for preventing excessive macrophage accumulation that can lead to chronic inflammation, tissue damage, and fibrosis. In cancer, tumor-associated macrophages can promote immunosuppression, and their proliferation is often dysregulated. Understanding the mechanisms that restrain macrophage proliferation may reveal new therapeutic targets for inflammatory diseases and cancer.
• Prevents excessive macrophage accumulation in tissues.
• Promotes resolution of inflammation and tissue repair.
• Dysregulation contributes to cancer progression and immunosuppression.
• Protects against ischemia-reperfusion injury in the heart.
• Limits liver inflammation and fibrosis.
• Modulates host defense against pathogens such as Pseudomonas aeruginosa.
• Influences tumor microenvironment and response to immunotherapy.
• Provides targets for anti-inflammatory and anti-cancer therapies.
What Happens During negative regulation of macrophage proliferation?
Initiation of negative regulatory signals
In simple terms: Signals that tell macrophages to stop dividing are received.
Negative regulation of macrophage proliferation begins when extracellular or intracellular cues activate pathways that inhibit cell cycle progression. For example, the SPP1-SOCS1 pathway constrains interferon responses in tumor-associated macrophages, limiting their proliferation. Similarly, ATF3 coordinates survival and proliferation of cardiac macrophages, acting as a negative regulator under stress conditions.
Transcriptional control of proliferation genes
In simple terms: Master switches in the cell turn off genes needed for division.
Transcription factors such as ATF3 modulate the expression of genes involved in cell cycle and survival, thereby reducing macrophage proliferation. In liver inflammation, fibroblast activation protein (FAP) activates macrophages and promotes parenchymal liver inflammation, but negative regulatory mechanisms may counteract excessive proliferation.
Cell cycle arrest and survival modulation
In simple terms: The cell cycle is halted, and cells may undergo apoptosis or remain quiescent.
Negative regulation often involves induction of cell cycle inhibitors and modulation of survival pathways. SIRT1 regulates macrophage pyroptosis during Pseudomonas aeruginosa-induced pneumonia, influencing macrophage fate and proliferation. In cardiac macrophages, ATF3 promotes survival while limiting proliferation, protecting against ischemia-reperfusion injury.
Resolution of inflammation and tissue homeostasis
In simple terms: Once the threat is gone, macrophages stop multiplying to allow healing.
Successful negative regulation leads to reduced macrophage numbers and resolution of inflammation. In liver fibrosis, targeting FAP reduces macrophage activation and inflammation, highlighting the importance of negative regulation. In cancer, modulating macrophage proliferation can reshape the tumor microenvironment and enhance anti-tumor immunity.
Key Genes Involved in GO:0120042 negative regulation of macrophage proliferation
The following genes and proteins have been experimentally implicated in negative regulation of macrophage proliferation or related processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATF3 | Transcription factor coordinating survival and proliferation of cardiac macrophages | Protects against ischemia-reperfusion injury |
| SPP1 | Secreted protein constraining interferon responses in tumor-associated macrophages | Shapes immunosuppressive tumor microenvironment |
| SOCS1 | Suppressor of cytokine signaling, limits interferon responses | Constrains macrophage proliferation in tumors |
| SIRT1 | Deacetylase regulating macrophage pyroptosis | Modulates macrophage fate in pneumonia |
| FAP | Fibroblast activation protein, activates macrophages | Promotes liver inflammation and fibrosis |
| HLF | Transcription factor regulating ferroptosis and tumor-macrophage crosstalk | Influences triple-negative breast cancer progression |
| CSF1R | Receptor for macrophage colony-stimulating factor | Controls macrophage proliferation and survival |
| IL-10 | Anti-inflammatory cytokine | Suppresses macrophage activation and proliferation |
| TGF-beta | Cytokine inhibiting macrophage proliferation | Promotes tissue repair and fibrosis |
| IFN-gamma | Cytokine activating macrophages | Can inhibit proliferation under certain conditions |
| NF-kB | Transcription factor regulating inflammation | Modulates macrophage survival and proliferation |
| mTOR | Kinase regulating cell growth and proliferation | Integrates signals to control macrophage proliferation |
| AMPK | Energy sensor kinase | Restrains proliferation under metabolic stress |
| p53 | Tumor suppressor | Induces cell cycle arrest in macrophages |
| p21 | Cyclin-dependent kinase inhibitor | Mediates cell cycle arrest |
| Bcl-2 | Anti-apoptotic protein | Modulates macrophage survival |
| Caspase-1 | Inflammasome effector | Regulates pyroptosis and proliferation |
How Is negative regulation of macrophage proliferation Regulated?
Negative regulation of macrophage proliferation is controlled by a network of signaling pathways, including cytokine signaling (e.g., SPP1-SOCS1), transcription factors (e.g., ATF3), and metabolic sensors (e.g., mTOR, AMPK). These pathways integrate environmental cues to halt proliferation when appropriate, such as during resolution of inflammation or in the tumor microenvironment.
negative regulation of macrophage proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATF3 | Cardiac ischemia-reperfusion injury | Cardiac macrophage-specific knockout |
| SPP1 | Tumor immunosuppression | Tumor-associated macrophage overexpression |
| SOCS1 | Cancer immunotherapy resistance | Macrophage-specific knockout |
| SIRT1 | Pseudomonas aeruginosa pneumonia | Macrophage-specific knockout |
| FAP | Liver fibrosis | FAP inhibitor treatment in mice |
Cancer
In cancer, tumor-associated macrophages often exhibit dysregulated proliferation, contributing to an immunosuppressive microenvironment. The SPP1-SOCS1 pathway constrains interferon responses in these macrophages, and its manipulation can alter tumor progression. Targeting negative regulatory pathways may enhance anti-tumor immunity.
Cardiovascular disease
ATF3 coordinates survival and proliferation of cardiac macrophages, protecting against ischemia-reperfusion injury. Loss of ATF3 leads to excessive macrophage proliferation and worsened injury, highlighting the therapeutic potential of enhancing negative regulation.
Liver fibrosis
Fibroblast activation protein (FAP) activates macrophages and promotes liver inflammation and fibrosis. Negative regulation of macrophage proliferation is essential to limit fibrosis, and targeting FAP reduces macrophage accumulation.
Infectious disease
SIRT1 regulates macrophage pyroptosis during Pseudomonas aeruginosa-induced pneumonia, influencing macrophage numbers and lung injury. Modulating negative regulation may affect host defense and tissue damage.
From negative regulation of macrophage proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate macrophage proliferation? | Conditional knockout in macrophages |
| Does a point mutation in gene Y alter macrophage proliferation? | Knock-in of point mutant |
| Does overexpression of gene Z reduce macrophage proliferation? | Transgenic overexpression |
| What is the role of gene W in cardiac macrophages? | Cardiac macrophage-specific knockout |
| How does gene V affect tumor-associated macrophages? | Tumor-associated macrophage-specific knockout |
| Does gene U regulate macrophage pyroptosis? | Macrophage-specific knockout |
How to Study the negative regulation of macrophage proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Cell proliferation and surface markers | Quantify macrophage proliferation in tissues |
| BrdU/EdU incorporation | DNA synthesis | Measure proliferation rate in vitro |
| RNA-seq | Transcriptional profiles | Identify regulators of macrophage proliferation |
| Conditional knockout | Gene function in specific cell types | Test candidate genes in macrophages |
| Western blot | Protein expression and signaling | Validate pathways |
| Immunohistochemistry | Tissue localization and proliferation markers | Assess macrophage accumulation in situ |
| CRISPR screening | Genome-wide identification of regulators | Discover novel negative regulators |
Flow cytometry
Flow cytometry is used to quantify macrophage proliferation by measuring DNA content or incorporation of thymidine analogs, as well as surface markers.
BrdU or EdU incorporation
These assays measure DNA synthesis to assess proliferation rates in macrophage populations in vitro and in vivo.
RNA sequencing
RNA-seq reveals transcriptional changes in macrophages under conditions that induce or inhibit proliferation, identifying key regulators.
Conditional knockout models
Cre-loxP systems allow macrophage-specific deletion of candidate genes to test their role in negative regulation of proliferation.
How CRISPR Can Be Used to Study GO:0120042 negative regulation of macrophage proliferation
Knockout
CRISPR knockout of candidate genes in macrophages or macrophage-like cell lines can determine whether they are required for negative regulation of proliferation. For example, knocking out ATF3 in cardiac macrophages may increase proliferation.
Point Mutation
Introducing point mutations in genes such as SOCS1 can reveal specific residues required for constraining interferon responses and limiting macrophage proliferation.
Knock-in
Knock-in of tagged or reporter genes allows tracking of macrophage proliferation and gene expression in vivo, as well as studying regulatory elements.
Overexpression
Overexpression of negative regulators like ATF3 or SOCS1 in macrophages can suppress proliferation and reduce inflammation in disease models.
How EDITGENE Supports negative regulation of macrophage proliferation Research
Researchers studying negative regulation of macrophage proliferation-related genes often need to determine whether a candidate gene is causally involved in restraining macrophage expansion. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of macrophage proliferation research.
Frequently Asked Questions About negative regulation of macrophage proliferation
What is negative regulation of macrophage proliferation?
It is any process that stops, prevents, or reduces the frequency, rate or extent of macrophage proliferation, as defined by GO:0120042.
What genes are involved in negative regulation of macrophage proliferation?
Key genes include ATF3, SPP1, SOCS1, SIRT1, and FAP, among others.
How is macrophage proliferation measured?
Common methods include flow cytometry, BrdU/EdU incorporation, and Ki-67 staining.
Why is negative regulation of macrophage proliferation important in cancer?
It prevents excessive tumor-associated macrophage accumulation that can suppress anti-tumor immunity.
What diseases are linked to dysregulated macrophage proliferation?
Cancer, cardiovascular disease, liver fibrosis, and pneumonia are associated with impaired negative regulation.
Can CRISPR be used to study negative regulation of macrophage proliferation?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect gene function in this process.
What is the role of ATF3 in macrophage proliferation?
ATF3 coordinates survival and proliferation of cardiac macrophages, acting as a negative regulator to protect against ischemia-reperfusion injury.
How does the SPP1-SOCS1 pathway affect macrophages?
It constrains interferon responses in tumor-associated macrophages, limiting their proliferation and shaping an immunosuppressive microenvironment.
What experimental models are used to study negative regulation of macrophage proliferation?
Conditional knockout mice, bone marrow-derived macrophages, and CRISPR-engineered cell lines are commonly used.
What services does EDITGENE offer for macrophage research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to macrophage biology.
Conclusion
Negative regulation of macrophage proliferation (GO:0120042) is a critical biological process that restrains macrophage expansion to prevent chronic inflammation and tissue damage. Key regulators such as ATF3, SPP1-SOCS1, and SIRT1 have been implicated in cancer, cardiovascular disease, and infections. Understanding these mechanisms offers therapeutic opportunities, and CRISPR-based models are indispensable for dissecting the underlying pathways. EDITGENE provides comprehensive services to accelerate this research.
References
- 1. Mantovani A et al.. 2022. Macrophages as tools and targets in cancer therapy.. Nat Rev Drug Discov 21(11):799-820 PMID: 35974096
- 5. Shao Y et al.. 2024. ATF3 coordinates the survival and proliferation of cardiac macrophages and protects against ischemia-reperfusion injury.. Nat Cardiovasc Res 3(1):28-45 PMID: 39195894
- 6. Sun L et al.. 2026. An SPP1-SOCS1 pathway constrains interferon responses in tumor-associated macrophages and shapes an immunosuppressive tumor microenvironment.. Immunity 59(5):1422-1437.e9 PMID: 42049035
- 7. Yang AT et al.. 2023. Fibroblast Activation Protein Activates Macrophages and Promotes Parenchymal Liver Inflammation and Fibrosis.. Cell Mol Gastroenterol Hepatol 15(4):841-867 PMID: 36521660
- 8. Ding H et al.. 2025. Regulation of macrophage pyroptosis by SIRT1 during Pseudomonas aeruginosa-induced pneumonia.. Mol Immunol 185:92-104 PMID: 40714269
